loadpatents
Patent applications and USPTO patent grants for Lynch; David H..The latest application filed is for "dendritic cell stimulatory factor".
Patent | Date |
---|---|
Dendritic cell stimulatory factor App 20090075886 - BRASEL; Kenneth ;   et al. | 2009-03-19 |
Methods for analyzing inter-cellular phenomena Grant 7,450,229 - Ortyn , et al. November 11, 2 | 2008-11-11 |
Methods of using flt3-ligand in the treatment of fibrosarcoma Grant 7,361,330 - Lynch , et al. April 22, 2 | 2008-04-22 |
Vaccine composition comprising Flt3-ligand App 20060292166 - Lynch; David H. ;   et al. | 2006-12-28 |
Methods of preparing dendritic cells with flt3-ligand and antigen Grant 7,150,992 - Lynch , et al. December 19, 2 | 2006-12-19 |
Coffee pod making method and apparatus App 20060201329 - Lynch; David H. | 2006-09-14 |
Methods for analyzing inter-cellular phenomena App 20060068371 - Ortyn; William E. ;   et al. | 2006-03-30 |
Synthetic turf groomer Grant D514,597 - Lynch February 7, 2 | 2006-02-07 |
Materials and methods for the prevention or treatment of apoptosis and apoptosis-related diseases and conditions App 20050020580 - Badley, Andrew D. ;   et al. | 2005-01-27 |
Method of enhancing lymphocyte-mediated immune responses App 20040247563 - Lynch, David H. ;   et al. | 2004-12-09 |
Method for treatment of tumors using combination therapy App 20040131587 - Thomas, Elaine K. ;   et al. | 2004-07-08 |
Use of flt3-ligand in the treatment of infection App 20040037845 - Brasel, Kenneth ;   et al. | 2004-02-26 |
Flt3-ligand as a vaccine adjuvant App 20030165531 - Lynch, David H. ;   et al. | 2003-09-04 |
Methods of using FLT3-ligand in the treatment of cancer App 20030113341 - Lynch, David H. ;   et al. | 2003-06-19 |
Bispecific antibodies that bind TRAIL-R1 and TRAIL-R2 App 20020155109 - Lynch, David H. | 2002-10-24 |
Dendritic Cell Stimulatory Factor App 20020034517 - BRASEL, KENNETH ;   et al. | 2002-03-21 |
Fas antagonists and uses thereof Grant 5,830,469 - Lynch , et al. November 3, 1 | 1998-11-03 |
Human anti-Fas IgG1 monoclonal antibodies Grant 5,620,889 - Lynch , et al. April 15, 1 | 1997-04-15 |
Adoptive immunotherapy with interleukin-7 Grant 5,229,115 - Lynch July 20, 1 | 1993-07-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.